The U.S. Food and Drug Administration issued letters to several companies -- including major pharmacy chains -- this week, warning them against manufacturing or selling unapproved eye products.

When Zepbound, Eli Lilly's highly anticipated weight loss drug, hit the market a year and a half ago, it marked a turning point for the accessibility of weight loss drugs. Since then, Zepbound, the ...

Pharmacy benefit manager CVS Caremark decided to replace Zepbound with Wegovy for use in weight loss starting July 1, despite Zepbound users having more weight loss success. The company will no longer ...

The FDA said it would start releasing rejection letters soon after they are provided to drugmakers, a victory for those who ...